Edgar Filing: VioQuest Pharmaceuticals, Inc.

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

LENZ BRIAN

2. Issuer Name and Ticker or Trading Symbol
VioQuest Pharmaceuticals, Inc. [VQPH]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
CFO and Treasurer

(Last)

(First)

(Middle)

180 MT. AIRY ROAD, SUITE 102

3. Date of Earliest Transaction (Month/Day/Year)
06/13/2008

(Street)

BASKING RIDGE, NJ 07920

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock								1,500 ⁽¹⁾	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Warrant

$ 4 ⁽¹⁾

06/29/2007

06/29/2012

Common Stock, $.001 par value

328 ⁽¹⁾

Warrant

$ 1 ⁽¹⁾

04/09/2008

04/09/2013

Common Stock

8,333 ⁽¹⁾

Series B Convertible Preferred Stock

$ 3.8 ⁽¹⁾

03/14/2008

⁽⁸⁾

Series A Convertible Preferred Stock

0.285

Series A Convertible Preferred Stock

$ 0.6 ⁽¹⁾

04/09/2008

⁽⁸⁾

Common Stock

8,333 ⁽¹⁾

Stock Options

$ 16.7 ⁽¹⁾

06/13/2008

D⁽²⁾

1,500 ⁽¹⁾

⁽²⁾

10/06/2013

Common Stock

1,500 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽²⁾

1,500

⁽²⁾

10/06/2013

Common Stock

1,500

$ 0

1,500

Stock Options

$ 14 ⁽¹⁾

06/13/2008

D⁽³⁾

2,500 ⁽¹⁾

⁽³⁾

04/19/2014

Common Stock

2,500 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽³⁾

2,500

⁽³⁾

04/19/2014

Common Stock

2,500

$ 0

2,500

Stock Options

$ 10.8 ⁽¹⁾

06/13/2008

D⁽⁴⁾

6,000 ⁽¹⁾

⁽⁴⁾

01/24/2015

Common Stock

6,000 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽⁴⁾

6,000

⁽⁴⁾

01/24/2015

Common Stock

6,000

$ 0

6,000

Stock Options

$ 10.3 ⁽¹⁾

06/13/2008

D⁽⁵⁾

10,000 ⁽¹⁾

⁽⁵⁾

11/29/2015

Common Stock

10,000 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽⁵⁾

10,000

⁽⁵⁾

11/29/2015

Common Stock

10,000

$ 0

10,000

Stock Options

$ 8.5 ⁽¹⁾

06/13/2008

D⁽⁶⁾

10,000 ⁽¹⁾

⁽⁶⁾

03/31/2016

Common Stock

10,000 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽⁶⁾

10,000

⁽⁶⁾

03/31/2016

Common Stock

10,000

$ 0

10,000

Stock Options

$ 5.5 ⁽¹⁾

06/13/2008

D⁽⁷⁾

10,000 ⁽¹⁾

⁽⁷⁾

05/11/2007

Common Stock

10,000 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽⁷⁾

10,000

⁽⁷⁾

05/11/2017

Common Stock

10,000

$ 0

10,000

Stock Options

$ 1.2 ⁽¹⁾

06/13/2008

D⁽⁹⁾

8,000 ⁽¹⁾

⁽⁹⁾

02/28/2018

Common Stock

8,000 ⁽¹⁾

$ 0

Stock Options

$ 0.54

06/13/2008

A⁽⁹⁾

8,000

⁽⁹⁾

02/28/2018

Common Stock

8,000

$ 0

8,000

Stock Options

$ 0.54

06/13/2008

80,000

⁽¹⁰⁾

06/13/2018

Common Stock

80,000

$ 0

80,000

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
LENZ BRIAN 180 MT. AIRY ROAD, SUITE 102 BASKING RIDGE, NJ 07920			CFO and Treasurer

Signatures

/s/ Brian Lenz		06/16/2008
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Adjusted to reflect a 1-for-10 reverse stock split effective on 4/25/2008.
(2)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 10/6/2003 and is fully vested.
(3)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 4/19/2004 and is fully vested.
(4)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 1/24/2005 and is fully vested.
(5)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 11/29/2005 and provides for vesting in three annual installments beginning on 11/29/06.
(6)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 3/31/2006 and provides for vesting in three annual installments beginning on 3/31/07.
(7)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 5/11/2007 and provides for vesting in three annual installments beginning on 5/11/2008.
(8)	No expiration date.
(9)	This transaction involves an amendment to an outstanding option, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on 2/28/2008 and provides for vesting in three annual installments beginning on 2/28/09 and is subject to acceleration under certain circumstances.
(10)	Option vests in three annual installments beginning on 6/13/08.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.